Clinical Trial Update: RAD001 in Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of RAD001 (everolimus) in advanced hepatocellular carcinoma has completed enrollment. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• RAD001 (Everolimus) (everolimus)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-02-07